Insufficient scRNA-seq data for expression of NRTN at single-cell level.
Insufficient scRNA-seq data for expression of NRTN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 366.24 | 226 / 226 | 98% | 16.33 | 397 / 406 |
| esophagus | 98% | 401.32 | 1420 / 1445 | 92% | 7.91 | 168 / 183 |
| pancreas | 100% | 453.46 | 328 / 328 | 84% | 5.28 | 149 / 178 |
| intestine | 97% | 315.39 | 934 / 966 | 86% | 5.98 | 451 / 527 |
| stomach | 99% | 373.99 | 356 / 359 | 82% | 7.33 | 234 / 286 |
| kidney | 91% | 129.15 | 81 / 89 | 87% | 11.15 | 781 / 901 |
| prostate | 90% | 150.80 | 220 / 245 | 66% | 2.71 | 330 / 502 |
| adrenal gland | 100% | 360.60 | 258 / 258 | 42% | 9.26 | 96 / 230 |
| skin | 71% | 182.53 | 1293 / 1809 | 63% | 8.53 | 298 / 472 |
| bladder | 76% | 235.81 | 16 / 21 | 55% | 3.58 | 277 / 504 |
| lung | 33% | 31.30 | 191 / 578 | 68% | 5.32 | 783 / 1155 |
| heart | 98% | 719.10 | 844 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 7.44 | 76 / 80 |
| uterus | 14% | 14.46 | 24 / 170 | 78% | 10.46 | 358 / 459 |
| ovary | 0% | 0 | 0 / 180 | 91% | 18.92 | 392 / 430 |
| breast | 38% | 40.69 | 173 / 459 | 45% | 4.34 | 499 / 1118 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 7.65 | 33 / 45 |
| thymus | 10% | 7.31 | 65 / 653 | 29% | 2.55 | 176 / 605 |
| brain | 3% | 1.85 | 73 / 2642 | 8% | 0.43 | 59 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.64 | 3 / 29 |
| adipose | 4% | 2.78 | 45 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 2% | 1.09 | 4 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 1% | 1.93 | 18 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 1.00 | 10 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0021675 | Biological process | nerve development |
| GO_0007399 | Biological process | nervous system development |
| GO_0035860 | Biological process | glial cell-derived neurotrophic factor receptor signaling pathway |
| GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
| GO_0001755 | Biological process | neural crest cell migration |
| GO_0000165 | Biological process | MAPK cascade |
| GO_0031175 | Biological process | neuron projection development |
| GO_0005615 | Cellular component | extracellular space |
| GO_0030424 | Cellular component | axon |
| GO_0005576 | Cellular component | extracellular region |
| GO_0030116 | Molecular function | glial cell-derived neurotrophic factor receptor binding |
| GO_1904399 | Molecular function | heparan sulfate binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0030971 | Molecular function | receptor tyrosine kinase binding |
| GO_0008083 | Molecular function | growth factor activity |
| Gene name | NRTN |
| Protein name | Neurturin |
| Synonyms | |
| Description | FUNCTION: Supports the survival of sympathetic neurons in culture. May regulate the development and maintenance of the CNS. Might control the size of non-neuronal cell population such as haemopoietic cells. |
| Accessions | Q99748 ENST00000303212.3 |